NCT00174187View on ClinicalTrials.gov

Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy

PHASE3TerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Endocrine System Diseases
Interventions
DRUG

Somatropin

liquid, daily, until final height Dosage: 0,46 mg/kg/week . The maximum dose should not exceed 50 µg/Kg/day

Trial Locations (2)

75019

Pfizer Investigational Site, Paris

75743

Pfizer Investigational Site, Paris

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY